Pfizer
-
Two people experiencing an allergic reaction to the Pfizer vaccine is not a cause for panic
Nicholas Wood, The Conversation Ketaki Sharma, The Conversation
-
Coronavirus: India’s tally rises to 98.26 lakh, new cases stay below 40,000 for 13th straight day
Scroll Staff
-
Coronavirus: US drug regulator authorises Pfizer vaccine for emergency use
Scroll Staff
-
Coronavirus: Britain’s AstraZeneca to test combining its vaccine with Russia’s Sputnik V
Scroll Staff
-
Coronavirus: US drug regulator’s panel of experts approves Pfizer vaccine for emergency use
Scroll Staff
-
Coronavirus: UK medicine regulator issues anaphylaxis warning on Pfizer vaccine
Scroll Staff
-
Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator
Scroll Staff
-
Coronavirus vaccines are here, but delivering them to billions of people is the next big challenge
Liz Breen, The Conversation Sarah Schiffling, The Conversation
-
Coronavirus: Indian-origin couple among first to get Pfizer vaccine in UK
Scroll Staff
-
As Covid-19 vaccines are ready to take off, here’s how Mumbai airport is gearing up for its delivery
Niharika Sharma, qz.com
-
Coronavirus: India’s tally rises to 96.44 lakh with 36,011 new cases
Scroll Staff
-
Covid-19: Does it make sense to vaccinate India’s entire population?
Manavi Kapur, qz.com
-
Coronavirus: UK clears Pfizer’s vaccine for emergency use, roll out from next week
Scroll Staff
-
Covid-19 vaccines are being developed in a record time. Is this reason to be wary?
Mark Toshner, The Conversation
-
Oxford AstraZeneca vaccine is a global game-changer even with 70% efficiency in initial trials
Michael Head, The Conversation
-
Coronavirus: ‘India might not need Pfizer vaccine,’ says health minister
Scroll Staff
-
Coronavirus: Pfizer applies for emergency use of its vaccine in US, approval expected mid-December
Scroll Staff
-
How do Pfizer and Moderna vaccines work? And why do they need to be kept so cold?
Sanjay Mishra, The Conversation
-
Covid-19: Pfizer-BioNTech vaccine delivery could start before Christmas if all goes well, says CEO
Scroll Staff
-
The big news: Pfizer’s Covid-19 vaccine 95% effective in final analysis, and nine other top stories
Scroll Staff